Determination of SA-446 in Human Whole Blood and Urine by Electron Capture-Gas Liquid Chromatography
スポンサーリンク
概要
- 論文の詳細を見る
A highly sensitive and specific gas chromatographic method for the determination of SA-446 [(2R, 4R)-2-(2-hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic acid] in human whole blood and urine was established. The mercapto group of SA-446 was alkylated completely with pentafluorobenzyl bromide (PFBB) and then the remaining hydroxyl and carboxyl groups were methylated with diazomethane. As little as 10 picograms of the derivatized SA-446 is detectable by the electron capture technique. The mean recoveries of SA-446 from whole blood and urine by the present method were 95.5% and 93.5%, respectively. The calibration curves for SA-446 were linear in the concentration ranges of 10ng/ml to 10000ng/ml of whole blood and 0.1μg/ml to 100μg/ml of urine. The standard deviation with this method was below 3.0%. This method is highly sensitive, and a small sample size of 250μl is enough to determine SA-446 in human whole blood and urine.
- 社団法人日本薬学会の論文
- 1982-06-25
著者
-
高階 秀男
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
岩尾 順一
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
岩尾 順一
Central Research Laboratories Santen Pharmaceutical Co. Ltd.
-
高階 秀男
参天製薬株式会社研究部
-
岩谷 照道
参天製薬株式会社研究部
-
岩谷 照道
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
内藤 雅嗣
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
永森 慎一
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
伊藤 義次
Research Laboratory, Santen Pharmaceutical Co., Ltd.
-
永森 慎一
Research Laboratory Santen Pharmaceutical Co. Ltd.
-
内藤 雅嗣
Research Laboratory Santen Pharmaceutical Co. Ltd.
-
伊藤 義次
Research Laboratory Santen Pharmaceutical Co. Ltd.
関連論文
- Thiol Compounds. I. Synthesis and Antihypertensive Activity of Mercaptoacylamino Acids
- ジチオール化合物の代謝研究(第1報)ラットにおけるN-(2-Mercapto-2-methylpropanoyl)-L-cysteine(SA96)の血中, 尿中代謝物の単離及び同定
- Determination of SA-446 in Human Whole Blood and Urine by Electron Capture-Gas Liquid Chromatography
- Thiol Compounds. II. Synthesis and Antihypertensive Activity of Mercaptoacylamino Acids
- 新規抗アレルギー点眼剤アレギサール^【○!R】 (TBX) 点眼液の作用持続性
- Synthesis and Aldose Reductase Inhibitory Activity of N-Acylthiazolidinecarboxylic Acids
- Synthesis and Calcium Antagonistic Activity of (+)-(R)- and (-)-(S)-3-Acetyl-2-[5-methoxy-2-[4-[N-methyl-N-(3,4,5-trimethoxyphenethyl)amino]butoxy]phenyl]benzothiazoline Hydrochloride
- Synthesis and Antihypertensive Activity of 5-(2-Hydroxyphenyl)-1-(3-mercaptopropionyl)-2-pyrrolidinecarboxylic Acids
- Synthesis and Aldose Reductase Inhibitory Activity of Thiazolidinecarboxylic Acids Containing a Disulfide Bond
- Conversion of Thiols into Disulfides with Diethyl Bromomalonate
- Thiol Compounds. V. Absolute Configuration and Crystal Structure of (4R)-2-(2-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic Acid
- Synthesis of Hydrazone Derivatives of 3a, 4-Dihydroadrenochrome-3a-sulfides and Determination of Their Hemostatic Activities
- Thiol Compounds. III. Synthesis and Antihypertensive Activity of Mercaptoacylamino Acids
- アンジオテンシン変換酵素阻害剤の合成と薬効 (「医薬品開発をめぐる生理活性物質の合成」特集号)
- New Sulfhydryl Compounds with Potent Antihypertensive Activities
- Iodoplatinate によるポストカラム配位子交換反応を用いる有機硫黄化合物の高速液体クロマトグラフィー. : アンギオテンシン変換酵素阻害剤(2R, 4R)-2-(o-Hydroxyphenyl)-3-(3-mercaptopropionyl)-4-thiazolidinecarboxylic Acid (SA446) とその尿中代謝物の同時定量への応用(生物学及び生化学)
- ジチオール化合物の代謝研究(第2報)ラット及びイヌにおける血中と尿中のN-(2-Mercapto-2-methylpropanoyl)-L-cysteine(SA96)及び関連代謝物の定量
- 有色ラットにおける0.5% ^C-レボフロキサシン (LVFX) 点眼液点眼後の体内動態
- 有色ウサギにおけるレボフロキサシン点眼液点眼後の眼内動態
- レボフロキサシンの眼内移行に及ぼすpHの影響
- オフロキサシンおよびレボフロキサシン点眼液の薬動力学的パラメーター
- アンジオテンシン変換酵素阻害剤の合成と薬効